# Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

> **NCT00949052** · — · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 1000 (actual)

## Conditions studied

- Cancer

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** polymorphism analysis
- **OTHER:** laboratory biomarker analysis
- **OTHER:** medical chart review
- **OTHER:** questionnaire administration
- **PROCEDURE:** assessment of therapy complications
- **PROCEDURE:** evaluation of cancer risk factors

## Key facts

- **NCT ID:** NCT00949052
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2014-12
- **Final completion:** 2018-02
- **Target enrollment:** 1000 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949052, "Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00949052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*